Profile: Ishares Nasdaq Biotechnology (IBB.O)
173.02USD
19 Jun 2013
$-3.53 (-2.00%)
$176.55
$176.67
$177.05
$172.96
479,073
700,723
$186.98
$124.81
iShares Nasdaq Biotechnology Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index consists of securities of NASDAQ-listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, and which also meet other eligibility criteria. The Index is one of the eight sub-indices of the NASDAQ Composite, which measures all common stocks listed on The NASDAQ Stock Market, Inc.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund’s investment advisor is Barclays Global Fund Advisors.
Company Address
Ishares Nasdaq Biotechnology
45 FREMONT STREET
SAN FRANCISCO CA 94105
P: +1415.5972000
F: +1415.6185014
Company Web Links
| Name | Compensation |
|---|---|
George Parker |
-- |
Michael Latham |
-- |
Jack Gee |
-- |
Geoffrey Flynn |
-- |
Amy Schioldager |
-- |

